TABLE 5.
Fimbrial serotype comparison within periods between isolates from vaccinated and unvaccinated individuals during trial I, as well as for surveillance years (1997-2000)
| Serotype | Trial I (1992-1995)a
|
Surveillance (1997-2000)a
|
||
|---|---|---|---|---|
| Vaccinated | Placebo | Vaccinated | Unvaccinated | |
| 2 | 27 (64%) | 97 (88%) | 95 (34%) | 240 (49%) |
| 3 | 7 (17%) | 7 (6%) | 167 (60%) | 228 (47%) |
| 2,3 | 8 (19%) | 6 (6%) | 10 (4%) | 17 (3%) |
| Autoagglutination | 7 (2%) | 3 (1%) | ||
| Total | 42 (100%) | 110 (100%) | 279 (100%) | 488 (100%) |
a
P < 0.01 within period.